<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Breast cancer":6,
"Prognosis":3,
"SOX17":1,
"cancer stem-like cells":1,
"epithelial-mesenchymal-transition":1,
"linc00617":1,
"long noncoding RNA":2,
"Adjuvant endocrine therapy":1,
"Leuprorelin acetate 6-month depot":1,
"Luteinizing hormone–releasing hormone agonist":1,
"Ovarian function suppression":1,
"Premenopausal hormone receptor-positive breast cancer":1,
"Anaplastic thyroid carcinoma":3,
"Distant metastases":1,
"Genetic abnormalities":1,
"Poorly differentiated thyroid carcinoma":1,
"Biopsy":1,
"Core-needle biopsy":1,
"Fine-needle aspiration biopsy":1,
"Thyroid· Thyroid lesions":1,
"endoscopic":1,
"retroauricular":1,
"solo-surgeon":1,
"solo-surgery":1,
"thyroidectomy":2,
"Características ultrassonográficas":1,
"Escore":1,
"Malignidade de tireoide":1,
"Nódulo tireoidiano":1,
"Scoring":1,
"Suspeito":1,
"Suspicious":1,
"Thyroid malignancy":1,
"Thyroid nodule":7,
"Ultrasound characteristics":1,
"Copper":1,
"Iron":1,
"Selenium":1,
"Thyroid cancer":27,
"Zinc":1,
"false negative results":1,
"fine-needle aspiration":2,
"sensitivity and specificity":1,
"thyroid nodules":5,
"thyroid surgery":2,
"Alcohols":1,
"Case-control studies":2,
"Risk factors":2,
"Smoking":1,
"Thyroid neoplasms":11,
"ESRD":1,
"TSH":1,
"nodular goiter":1,
"thyroid gland":3,
"urinary iodine excretion":1,
"HISTOPATHOLOGY":1,
"MOLECULAR PATHOLOGY":1,
"Acoustic analysis":1,
"Radioactive iodine therapy":2,
"Total thyroidectomy":2,
"Voice":1,
"Well-differentiated thyroid cancer":1,
"Human herpesvirus 4":1,
"Nasopharynx":2,
"Papillary adenocarcinoma":1,
"Thyroid nuclear factor 1":1,
"Gas inflation":1,
"Single-incision endoscopic thyroidectomy":1,
"Trans-axillary endoscopic thyroidectomy":1,
"(131)I therapy":1,
"2D gamma-camera image":1,
"Activity quantification":1,
"Artefacto en la imagen de gammacámara":1,
"Colimador de alta energía":1,
"Corrector filter":1,
"Cuantificación de la actividad":1,
"Filtro corrector":1,
"Fourier transform":1,
"Gamma camera image artifact":1,
"High-energy collimator":1,
"Imagen de gammacámara 2D":1,
"Terapia con (131)I":1,
"Transformada de Fourier":1,
"Merkel cell carcinoma":1,
"histology":1,
"neuroendocrine carcinoma":1,
"parotid gland":2,
"survival":3,
"I-131":1,
"predictive factors":1,
"thyroglobulin":3,
"thyroid ablation failure":1,
"BRAF":3,
"lncRNA":2,
"migration":3,
"papillary thyroid cancer":5,
"proliferation":2,
"Drainage":1,
"Hematoma":1,
"Surgical outcomes":1,
"Conventional":1,
"Endoscopic thyroidectomy":1,
"Gasless":1,
"Transaxillary":1,
"Hyponatremia":1,
"Hypothyroidism":4,
"RAI therapy":1,
"Hypopharyngeal":1,
"Laryngeal":1,
"Negative predictive value":1,
"Positive predictive value":1,
"Sensitivity":1,
"Specificity":1,
"Thyroid gland invasion":1,
"multicenter study":1,
"multimodal treatment":1,
"prognostic factor":1,
"surgery":2,
"Medullary thyroid carcinoma":1,
"Molecular biology":1,
"Papillary thyroid carcinoma":10,
"Simultaneous tumors":1,
"Hey1":1,
"activated Notch1":1,
"Elastography":1,
"Guidelines":1,
"Prostate cancer":1,
"Shear wave elastography":2,
"Strain elastography":1,
"Transient elastography":1,
"World Federation for Ultrasound in Medicine and Biology":1,
"Carcinoma":4,
"Immunohistochemistry":3,
"Lung":3,
"Pleomorphic carcinoma":1,
"Sarcomatoid carcinoma":1,
"Spindle cell carcinoma":1,
"125I seed brachytherapy":1,
"mucoepidermoid carcinoma":1,
"pediatric":1,
"CXCL1":1,
"CXCR1":1,
"CXCR2":1,
"Cancer stem cells":2,
"IL-8":1,
"Thyroid autoimmunity":1,
"Vitamin D":1,
"Color flow Doppler sonography":1,
"Initial assessment":1,
"Thyrotropin":2,
"ETV6-NTRK3 fusion":1,
"MASC":1,
"cytology":2,
"mammary analog secretory carcinoma":1,
"thyroid":9,
"RET":3,
"RET/PTC":1,
"cabozantinib":1,
"non-small cell lung cancer":1,
"precision medicine":1,
"vandetanib":1,
"Differentiated thyroid cancer":5,
"Excellent response":1,
"Preparation mode":1,
"Remnant ablation":1,
"Risk of recurrence":1,
"Thyroglobulin levels":1,
"Body mass index":1,
"Cancer":1,
"Incidence":2,
"Obesity":1,
"Classification":1,
"Convolutional neural network":1,
"Diagnosis":2,
"Feature extraction":1,
"Ultrasound image":1,
"Cowden syndrome":1,
"PTEN immunohistochemical stain":1,
"clear cell acanthoma":1,
"sebaceous lymphadenoma":1,
"trichilemmoma":1,
"Color Doppler ultrasonography":1,
"Neoplasm metastasis":1,
"Signet-ring-cell carcinoma":1,
"Stomach neoplasm":1,
"18FDG-PET":1,
"Differantiated thyroid cancer":1,
"P53 protein expression":1,
"complications":1,
"pediatrics":1,
"recurrence":2,
"Angiogenesis":1,
"EGFL7":1,
"EGFRvIII":1,
"Glioblastoma":1,
"Heterogeneity":2,
"antithyroglobulin antibodies":1,
"thyroglobulin mass spectrometry":1,
"BRAF mutation":2,
"Warburg effect":1,
"glycolysis":1,
"plump eosinophilic cell":1,
"RAS mutations":1,
"RET/PTC and PAX8/PPAR-gamma chromosomal rearrangements":1,
"benign thyroid lesions":1,
"molecular markers":1,
"brown adipose tissue":1,
"thermogenesis":1,
"thyroid hormone":1,
"thyrotoxicosis":1,
"metastasis":6,
"radioisotopes":1,
"thyroid neoplasm":3,
"ATA risk stratification":1,
"central neck dissection":2,
"disease recurrence":1,
"disease-free survival":1,
"reoperation":1,
"response to therapy":1,
"meta-analysis":4,
"non-total thyroidectomy":1,
"papillary thyroid microcarcinoma (PTMC)":1,
"recurrence rate":1,
"Iodine radioisotopes":1,
"Radiotherapy dosage":1,
"Hürthle cell neoplasm":1,
"PET/CT":1,
"follicular neoplasm":1,
"indeterminate":1,
"131I ablation":1,
"brain glucose metabolism":1,
"positron emission tomography":1,
"Lymph node metastasis":4,
"PNET":1,
"teratoma":1,
"treatment":2,
"tumor sequencing":1,
"TP53":1,
"anaplastic thyroid cancer":1,
"cfDNA":1,
"mutation":1,
"sequencing":1,
"Graves' disease":1,
"Hashimoto's thyroiditis":1,
"lymphocytic thyroiditis":1,
"papillary carcinoma":2,
"antigastric parietal cell antibody":1,
"antithyroglobulin antibody":1,
"antithyroid microsomal antibody":1,
"atrophic glossitis":1,
"recurrent aphthous stomatitis":1,
"follicular adenoma":1,
"follicular thyroid cancer":2,
"follicular variant papillary thyroid carcinoma":1,
"tissue microarray":1,
"Drosophila melanogaster":1,
"animal models":1,
"chick chorioallantoic membrane":1,
"medullary thyroid cancer":2,
"mice":1,
"zebrafish":1,
"VEGFs":1,
"lymphangiogenesis":1,
"nuclear receptor corepressor 1":1,
"thyroid hormone receptor beta 1":1,
"US elastography":1,
"fibronectin-1":1,
"fibrosis":1,
"galectin-3":1,
"indeterminate cytology":1,
"Attention network test":1,
"Endocrine therapy":1,
"Executive function":1,
"Tamoxifen":1,
"Cáncer diferenciado de tiroides":1,
"Defectos embrionarios del tiroides":1,
"Dysembriogenetic thyroid defects":1,
"Ectopic thyroid":1,
"Lingual thyroid":2,
"Quiste tirogloso":1,
"Thyroglossal duct cysts":1,
"Tiroides ectópico":1,
"Tiroides lingual":1,
"cancer biomarkers":1,
"poor prognosis":1,
"thyroid hormone receptor-interacting protein 13":1,
"Brain tumor":1,
"Glioma":2,
"Quality of life":1,
"Thyroid hormones":1,
"Tri-iodothyronine":2,
"Pediatric thyroid cancer":1,
"1,1′-Oxalyldiimidazole (ODI) chemiluminescence":1,
"Biosensor":1,
"Chemiluminescent enzyme immunoassay (CLEIA)":1,
"Nanoparticle":1,
"Stimulant hormone (TSH)":1,
"Tumor marker":1,
"adverse events":1,
"anti-PD1 antibodies":1,
"pruritus":1,
"Exotic cats":1,
"felids":1,
"neoplasia":1,
"parathyroid":1,
"cox regression model":1,
"epidemiology and end results (SEER) database":1,
"propensity score":1,
"surgery and radiation treatment":1,
"thyroid carcinoma":2,
"miR-375":1,
"MicroRNA":2,
"pancreatic ductal adenocarcinoma":1,
"tumor-suppressor ZFP36L2":1,
"BRAF V600E":1,
"WIPF1":1,
"oncogenesis":2,
"tumor aggressiveness":1,
"Differentiated thyroid carcinoma":1,
"Fluorodeoxyglucose-PET/computed tomography":1,
"High thyroglobulin and negative iodine scintigraphy":1,
"PET":1,
"Radioiodine scan":1,
"Radioiodine therapy":1,
"C14orf93":1,
"Exome sequencing":1,
"RTFC":1,
"RET isoforms":1,
"epithelial–mesenchymal transition":1,
"invasion":1,
"CD56, immunohistochemistry":1,
"adenomatous hyperplasia":1,
"extremely well-differentiated":1,
"follicular epithelial dysplasia":1,
"well-differentiated tumors of uncertain malignant potential":1,
"BRAF V600E mutation":1,
"RAS mutation":1,
"TERT promoter mutation":1,
"prognostic molecular markers":1,
"drug resistance":1,
"epithelial-mesenchymal transition":1,
"molecular targeted therapy":1,
"HCC":1,
"HFS":1,
"diarrhoea":1,
"hypertension":1,
"sorafenib":2,
"Cancer signaling":1,
"Estrogen":1,
"Gender medicine":1,
"Anti-NMDA receptor encephalitis":1,
"Differential diagnosis":1,
"Misdiagnosis":1,
"Tumor":1,
"Bethesda category III":1,
"acoustic radiation force impulse elastography":1,
"fine-needle aspiration cytology":1,
"ultrasound":2,
"NONHSAT076754":1,
"biomarker":3,
"ultrasonography":2,
"Betulin":1,
"Renal cell carcinoma":1,
"mTOR":1,
"Health Status Disparities":1,
"Minority Health":1,
"SEER Program":1,
"18F-FDG uptake":1,
"glucose metabolism":1,
"metformin":1,
"breast carcinoma in situ":1,
"outcomes":1,
"tumor subtype":1,
"BDNF":1,
"miR-497":1,
"tumorigenesis":1,
"HIT000218960":1,
"HMGA2":1,
"Anti-cancer":1,
"Apoptosis":1,
"Autophagy":1,
"Honokiol":1,
"Capecitabine":1,
"Chemotherapy":1,
"Cisplatin":1,
"Gastric cancer":1,
"Modified XP regimen":1,
"color Doppler":1,
"fine‐needle aspiration":1,
"head and neck ultrasound":1,
"intranodular vascularity":1,
"thyroid sonography":1,
"genomics":1,
"papillary thyroid carcinmona":1,
"radiation therapy":1,
"sarcoma":1,
"EphB3":1,
"Rho (Rho GTPase)":1,
"Vav2":1,
"cancer biology":1,
"cell migration":1,
"focal adhesion":1,
"quality measurement":1,
"shear wave speed imaging":1,
"differentiation":1,
"gene fusion":1,
"peroxisome proliferator-activated receptor gamma":1,
"pioglitazone":1,
"clinicopathological features":1,
"meta–analysis":1,
"mortality risk":1,
"tall cell variant":1,
"Induction chemotherapy":1,
"S-1":1,
"chemoradiotherapy":2,
"gemcitabine":1,
"pancreatic cancer":1,
"Contrast":1,
"BRAFV600E":1,
"Nthy-ori 3-1 cell":1,
"microarrays":1,
"signal transduction":1,
"Cdc42":1,
"ESCC":1,
"FLNC":1,
"Rac1":1,
"genetics":1,
"miRNA":2,
"predisposition":1,
"variants":1,
"diagnostic meta-analysis":1,
"thyroid stimulating hormone receptor":1,
"PKM2":1,
"ROS":1,
"SIRT5":1,
"succinylation":1,
"tumor growth":1,
"IHC":1,
"OLC1":1,
"gastric adenocarcinoma":1,
"subcellular expression":1,
"AIF = arterial input function":1,
"ASMase = acid sphingomyelinase":1,
"DCE = dynamic contrast-enhanced":1,
"FA = flip angle":1,
"FOV = field of view":1,
"HD IGRT = high-dose image-guided radiation therapy":1,
"Ktrans = vascular permeability":1,
"ROI = region of interest":1,
"Vp = plasma volume":1,
"dynamic contrast-enhanced MRI":1,
"high-dose image-guided radiation therapy":1,
"spine tumor response":1,
"EMT process":1,
"N-cadherin":1,
"major signaling pathways":1,
"National Institutes of Health":1,
"head and neck cancer":1,
"head and neck squamous cell carcinoma":1,
"Lung cancer":1,
"Metastatic vertebral tumor":1,
"Revised Tokuhashi score":1,
"Survival period":1,
"MYH9":1,
"bidirectional promoter":1,
"transcriptional regulation":1,
"age":1,
"cancer cases":1,
"cancer statistics":1,
"death rates":1,
"mortality":1,
"meningioma":1,
"Endoscopy":1,
"Graves’ disease":1,
"Neurosurgery":1,
"Pituitary neoplasms":1,
"TSH-producing tumor":1,
"TSHoma":1,
"miR-221":1,
"Autograft":1,
"Pasteurization":1,
"Periacetabular malignant bone tumour":1,
"Reconstruction":1,
"Epithelial-mesenchymal transition (EMT)":1,
"Estrogen receptor alpha (ERα)":1,
"MAP3K2":1,
"Triple negative breast cancer (TNBC)":1,
"miR-34c-3p":1,
"Aspergilloma":1,
"Case report":1,
"Radioiodine":1,
"SPECT/CT":1,
"Sinus":1,
"Atypical clinical presentation":1,
"Ependymoma":1,
"Filum terminale":1,
"Giant cell":1,
"Immunohistochemistry markers":1,
"Antiangiogenic tyrosine kinase inhibitor":1,
"Lenvatinib":1,
"cancer cell of origin":1,
"cancer genomics":1,
"noncoding genetic variation":1,
"somatic mutational processes":1,
"statistical driver discovery":1,
"variant topography":1,
"whole-genome sequencing":1,
"Thyroxine":1,
"Postoperative pain":1,
"CNB":1,
"FNA":1,
"Chernobyl":1,
"Fukushima":1,
"Radiation":1,
"Ultrasound screening":1,
"Early diagnosis":1,
"Genetic predisposition to disease":1,
"Genetic testing":1,
"Multilocus sequence typing":1,
"Cancer screening":1,
"Overdiagnosis":1,
"Overtreatment":1,
"Computed tomography":1,
"Incidentaloma":1,
"Technetium thyroid uptake":1,
"Thyroid scintigraphy":1,
"Epistasis":1,
"Gene-gene interactions":1,
"Genome-wide association study":1,
"Group Lasso":1,
"HES1":1,
"Tumor progression":1,
"miR-182":1,
"RASSF1A":1,
"methylation":1,
"high-frequency color ultrasonography":1,
"lymph node dissection":1,
"cardiac metastasis":1,
"disseminated intravascular coagulation":1,
"squamous cell carcinoma of the thyroid gland":1,
"PIK3CA":1,
"miR-363-3p":1,
"Papillary thyroid microcarcinoma":2,
"Ultrasonographic features":1,
"coffee":1,
"cohort studies":1,
"review":1,
"Frontal bone":1,
"occult follicular thyroid carcinoma":1,
"skull metastasis":1,
"Bethesda system":2,
"Category III":1,
"substratification":1,
"aneuploidy":1,
"cellsearch":1,
"circulating tumor cells (CTC)":1,
"subtraction enrichment":1,
"Epidermal growth factor receptor":1,
"female":1,
"nonsmall cell lung carcinoma":2,
"reirradiation":1,
"thyroid metastasis":1,
"131I-whole body scan":1,
"18F-fluorodeoxyglucose-positron emission tomography":1,
"follicular variant":1,
"renal metastasis":1,
"terminology":1,
"18-Fluorodeoxyglucose positron emission tomography":1,
"metaiodobenzylguanidine":1,
"neural crest cell tumor":1,
"differentially expressed gene":1,
"latent pathway analysis":1,
"protein-protein interaction network":1,
"significant pathway":1,
"Carcinoma de tiroides":1,
"DNA methylation":1,
"Epigenetics":1,
"Epigenética":1,
"Histone modifications":1,
"Metilación de DNA":1,
"Modificación de histonas":1,
"ectopic":1,
"pleura":1,
"circulating":1,
"follow-up":1,
"neck central lymph node metastasis":1,
"E-cadherin":1,
"serum":1,
"Canada":1,
"Cancer incidence":1,
"First Nations":1,
"Cytokeratin":1,
"isolated skeletal muscle metastasis":1,
"parathyroid hormone related peptide":1,
"skeletal muscle metastasis":1,
"thyroid transcription factor":1,
"ENTPD3":1,
"Extracellular ATP":1,
"GATA3":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年1月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
